Paula G. O’Connor, M.D., has served as the Senior Vice President of Clinical Development since September 2022. Dr. O’Connor is trained as a hematologist-oncologist with more than 15 years of drug development expertise. Prior to joining Nurix, Dr. O’Connor held senior level positions in Clinical Development and Medical Affairs at Protagonist Therapeutics, Oncopeptides, Inc., Coherus Biosciences, Medivation, Onyx, and Genentech. Dr. O’Connor completed her fellowships in Hematology, Oncology, and AIDS Oncology at the combined programs of the Massachusetts General, Brigham and Women’s, and Dana Farber Cancer Institute. She holds a B.A. in Psychology-Biology from Yale University and an M.D. from Stanford University.